Entellus Medical, Inc. Common Stock
ENTL
ENTL was delisted on the 27th of February, 2018.
0 hedge funds and large institutions have $0 invested in Entellus Medical, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 82 closing their positions.
100% less funds holding
Funds holding: 83 → 0 (-83)
100% less funds holding in top 10
Funds holding in top 10: 6 → 0 (-6)
100% less capital invested
Capital invested by funds: $441M → $0 (-$441M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 82
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
-$77.6M |
| 2 |
SHI
SV Health Investors
Boston,
Massachusetts
|
-$72.1M |
| 3 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
-$34.3M |
| 4 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
-$33.6M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$24.1M |
ENTL Hedge Fund Activity: Q1 2018 in Review
0 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Entellus Medical, Inc. Common Stock (ENTL) for Q1 2018, worth a combined $0 — down 100% from $441M a quarter earlier.
Sellers outnumbered buyers: 82 funds closed out of ENTL and 0 opened new positions — a net loss of 82 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Essex Woodlands Management, exiting entirely with an estimated $77.6M sold.
- 0 institutional investors held Entellus Medical, Inc. Common Stock (ENTL) as of Q1 2018, down from 83 in Q4 2017.
- Funds reported $0 of Entellus Medical, Inc. Common Stock stock for Q1 2018, down 100% quarter-over-quarter.
- 0 funds opened new Entellus Medical, Inc. Common Stock positions in Q1 2018 and 82 closed out, a net change of -82 holders.
- The largest Entellus Medical, Inc. Common Stock seller in Q1 2018 was Essex Woodlands Management, an estimated $77.6M sold.
Based on aggregated 13F filings for Q1 2018.